NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
19/12/2023
Voltar para busca
Dado oficial do USPTO
CAMBRIAN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
19/12/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
22/09/2021
Data de registro
19/12/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/12/2023
Última transação
19/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/07/2021
Primeiro uso no comércio
01/07/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY
Examinador
JARAMILLO, JAVIER
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cambrian BioPharma, Inc.
Representantes
Matthew D. Delaney FROST BROWN TODD LLC
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business incubator servicesproviding business management consulting and advisory services in the areas of corporate growth strategyinnovation and growth processesregulatory approvalstalent management to emerging and start-up biopharmaceutical companiesall of the foregoing excluding in the fields of renewable energyenergy generationstorage and distributionwater treatmentdevelopment of microbial fuel cells for othersindustrial biotechnology products and servicesproject financing and project development for waterrenewable energy and environmental treatment systems used in the medical fieldrenewable energy and environmental treatment systems used in manufacturingrenewable energy and environmental treatment systems used in industrial fieldsrenewable energy and environmental treatment systems used in hospitality fieldsrenewable energy and environmental treatment systems used in real estate fieldswater and energy related biomedical treatment controls and sensorswater treatment controls and sensorsrenewable energy and environmental treatment controls and sensorssoftware for use in connection with the foregoing
Classe 42
Scientific research consultation services in the field of biopharmaceuticals; medical research consultation services in the field of biopharmaceuticals; scientific research consultation pertaining to clinical trials of others; all of the foregoing excluding in the fields of renewable energyenergy generationstorage and distributionwater treatmentdevelopment of microbial fuel cells for othersindustrial biotechnology products and servicesproject financing and project development for waterrenewable energy and environmental treatment systems used in the medical fieldrenewable energy and environmental treatment systems used in manufacturingrenewable energy and environmental treatment systems used in industrial fieldsrenewable energy and environmental treatment systems used in hospitality fieldsrenewable energy and environmental treatment systems used in real estate fieldswater and energy related biomedical treatment controls and sensorswater treatment controls and sensorsrenewable energy and environmental treatment controls and sensorssoftware for use in connection with the foregoing
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
19/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/11/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/11/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
14/11/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/10/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/10/2023
IUAF
USE AMENDMENT FILED
29/09/2023
EISU
TEAS STATEMENT OF USE RECEIVED
29/09/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/04/2023
EX1G
SOU EXTENSION 1 GRANTED
24/04/2023
EXT1
SOU EXTENSION 1 FILED
24/04/2023
EEXT
SOU TEAS EXTENSION RECEIVED
24/04/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/11/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/09/2022
PUBO
PUBLISHED FOR OPPOSITION
20/09/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2022
ALIE
ASSIGNED TO LIE
02/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/07/2022
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
27/06/2022
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
27/06/2022
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
27/06/2022
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
27/06/2022
DOCK
ASSIGNED TO EXAMINER
24/06/2022
TAEA
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
01/06/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
01/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/10/2021
NWAP
NEW APPLICATION ENTERED
25/09/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CAMBRIAN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.